Genedata Partner Symposium 2026

March 10–March 11, 2026 | Basel, Switzerland

At the Genedata Partner Symposium 2026 leading biopharma companies shared how they transform their biotherapeutics R&D through AI/ML and LLM applications in biopharma, workflow automation and lab-in-the-loop, novel modalities (ADCs, Peptides, RNA, CGT), next-gen bioprocess development, advances in Mass Spectrometry (MAM, NPD), precision medicine, high-throughput chromatography, NGS-based drug development, GxP compliance, and SaaS deployment.

They showed how teams have set up, operate, and use Genedata solutions across all areas of biopharma:

AI — Data analysis, insights, and predictions
Automation — Laboratory, data, and research process automation
GxP — Bioprocessing, biosafety, and QC
Discovery — Screening, selection, engineering, and validation
Development/CMC — Characterization, optimization, and cell-line engineering
Precision Medicine — Patient profiling and integrative (pre-)clinical research

Are You a Genedata Customer? Stay tuned for details on the 2027 Genedata Partner Symposium.

Hear from Genedata Customers

Boehringer Ingelheim

Novartis

Pfizer

AstraZeneca

Merck

Johnson & Johnson

Sanofi

Ferring

Chugai

Genmab

BioCopy

Boehringer Ingelheim

Fresenius Kabi

Daiichi Sankyo

Novartis

AbbVie

Novartis

Boehringer Ingelheim

Sandoz

Charles River

Sanofi

Roche

Boehringer Ingelheim

Novartis

2026 Highlights

Read the Blog

Genedata R&D Excellence Awards 2026

The Genedata R&D Excellence Awards recognize outstanding contributions to digital biopharma R&D, spanning innovation, execution, enterprise-level transformation, and long-term leadership. The 2026 winners are:

Innovation Award Winners
Boehringer Ingelheim — Streamlining Analytical & Preparative Chromatography Workflows Across Teams & Sites at Boehringer Ingelheim
Kelli Grand, IT Business Consultant, Boehringer Ingelheim, Basel, Switzerland
Wolfgang Reindl, Principal Scientist, Boehringer Ingelheim, Biberach, Germany

Genedata Momentum Award Winner
Merck — AI in Action: Automating Request Management for mAbs, Bispecifics, and ADCs at Merck
Sameh Eid, Associate Scientific Director — Digital, Data & IT Healthcare, Merck, Darmstadt, Germany

Genedata Transformation Award Winner
Astellas — Driving Safety in Cell & Gene Therapy: Unlocking NGS and Regulatory Synergy for Maximum Impact
Tracie Fradet, Associate Director Cytogenomics, Astellas, Westborough, MA, USA

Genedata Visionary Award Winner
Pfizer — Evolution of the Genedata Biologics Ecosystem at Pfizer
Joel Bard, Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA

Agenda 2026

Day 1 — Tuesday, March 10, 2026
Plenary Session
8:30–9:00	Registration & Welcome Coffee
9:00–9:10	Opening Remarks Valentina Armiento, Science and Technology Manager, Genedata, Basel, Switzerland
9:10–9:30	AI-Native Approach to Biopharma R&D: Unifying Data, Workflows, and Insights Jana Hersch, Head of Science, Genedata, Lexington, MD, USA
9:30–10:00	Making Data Work: How Genedata Automates New R&D Workflows at AstraZeneca Lore Florin, Senior Director Discovery Platforms, AstraZeneca, Gaithersburg, MD, USA
10:00–10:30	Enabling MS-Based MAM in Characterization and QC Through a Robust New Peak Detection Workflow Thomas Pohl, Director Analytical Characterization, Novartis, Basel, Switzerland
10:30–11:00	Break
11:00–11:30	Streamlining Analytical & Preparative Chromatography Workflows Across Teams & Sites at Boehringer Ingelheim Kelli Grand, IT Business Consultant, Boehringer Ingelheim, Basel, Switzerland Wolfgang Reindl, Principal Scientist, Boehringer Ingelheim, Biberach, Germany
11:30–12:00	AI in Action: Automating Request Management for mAbs, Bispecifics, and ADCs at Merck Sameh Eid, Associate Scientific Director — Digital, Data & IT Healthcare, Merck, Darmstadt, Germany
12:00–12:30	Driving Safety in Cell & Gene Therapy: Unlocking NGS and Regulatory Synergy for Maximum Impact Tracie Fradet, Associate Director Cytogenomics, Astellas, Westborough, MA, USA
12:30–2:00	Lunch
Breakout Sessions
	Biotherapeutics Discovery	Assay Analysis & Management	Mass-Spec Data Analysis	Next-Gen Chromatography Workflows	NGS-Based Development & Biosafety
2:00–2:30	Evolution of the Genedata Biologics Ecosystem at Pfizer Joel Bard, Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA	Creating Momentum: Scaling Genedata Screener to Accelerate Biomedical Research at Novartis Markus Kroemer, Director Data Science, Novartis, Basel, Switzerland	Genedata Expressionist — Product Development Roadmap Aude Tartière, Head of Commercial, Expressionist, Genedata, San Francisco, CA, USA	Automated RNA Quality Assessment Across Different Electrophoresis Instruments Dennis Bellert, Senior Research Associate, Genmab, Utrecht, Netherlands	Genedata Selector — Product Development Roadmap Ludwig Macko, Head of Genedata Selector Development, Genedata, Basel, Switzerland
2:30–3:00	From Data to Discovery: Genedata Biologics and Data Governance as the Backbone of AI/ML Bjoern Hueber, Data Management Lead — Biologics Research Centre, Novartis, Basel, Switzerland Drazen Nadoveza, Complex Modalities Domain Architect, Novartis, Basel, Switzerland	Driving Efficiency and Data Quality in Compound Screening/Profiling with Genedata Screener at Evotec Jean-Philippe Navarro, Lab Automation Specialist, Evotec, Toulouse, France Matthias Catteau, Research Scientist, Evotec, Toulouse, France	AiDA Accelerates Top/Middle-Down MS Data Analysis Across Multiple Antibody Variants François Griaud, Senior Manager Analytical Characterization, Novartis, Basel, Switzerland	Towards Workflow Integration: Testing Chromatics for Advanced Protein Chromatography Analytics Ellen Kessler, Analytics Expert, Sanofi, Frankfurt, Germany	How Challenges in Biologics Development Catalyze Innovations in Cell Line Development Simon Fischer, Head of Cell Biology & Senior Principal Scientist, Boehringer Ingelheim, Biberach, Germany
3:00–3:30	Break
3:30–4:00	Accelerating Biologics Discovery Through Custom Integrations and Automated Genedata Workflows Debra Touw, Principal Scientist, Digital Strategy and Automation, AbbVie, Worcester, MA, USA	Integrating Screener into Enterprise Data Pipelines at Lundbeck Alexander Cahlin, Data Engineer, Lundbeck, Valby, Denmark	Development of a Workflow for Purity Assessment of Oligonucleotides and Their Conjugates Using Genedata Expressionist Annika Langborg Weinmann, Associate Principal Scientist, AstraZeneca, Gothenburg, Sweden	Streamlining Chromatography Analysis: How Chromatics Enhances AstraZeneca's Biologics Pipeline Mayanka Asthana, Associate Principal Scientist, AstraZeneca, Cambridge, UK	Development of Next Generation Sequencing–Based Workflows for Critical Quality Attributes for Product Characterization in Cell and Gene Therapy: Biosafety and Genome Integrity Andrew Hillhouse, Principal Scientist Group Lead, FUJIFILM Biotechnologies, College Station, TX, USA
4:00–4:30	Increasing Efficiency of Antibody Discovery and Engineering Workflows at Daiichi Sankyo Kota Inoue, Scientist, Research Function, Modality Research Laboratories II, Daiichi Sankyo, Tokyo, Japan	Integrating Screener into Enterprise Data Pipelines at Lundbeck Morten Hentzer, Research Fellow, Lundbeck, Valby, Denmark	MS-Based Characterization of AAV Capsid Proteins Using Genedata Expressionist Kate Groves, Senior Biophysical Scientist, UCB, Braine l'Alleud, Belgium	Genedata Chromatics — Product Development Roadmap Isabel Kolinko, Head of Genedata Chromatics, Genedata, Basel, Switzerland	Evolution of Regulatory Acceptance for NGS-Based Adventitious Virus Detection Dominik Meisohle, Principal Scientist, Boehringer Ingelheim, Biberach, Germany
4:30–5:00	Genedata Biologics — Product Development Roadmap Christoph Freiberg, Head of Science, Genedata, Basel, Switzerland	Genedata Screener — Product Development Roadmap Matthias Fassler, Product Manager, Genedata, Basel, Switzerland	Empowering Biosimilar Development via SaaS-Based Expressionist in the Cloud Daniel Ayoub, Senior Director of CMC Analytics, Fresenius Kabi, Nyon, Switzerland		Panel Discussion: From NGS Signal to GMP Decisions – and Where AI/ML Can Safely Help
5:15–6:00	Demo and Poster Session
6:00–8:00	Dinner

Day 2 — Wednesday, March 11, 2026
Plenary Session
8:30–9:00	Registration & Welcome Coffee
9:00–9:15	Opening Remarks Valentina Armiento, Science and Technology Manager, Genedata, Basel, Switzerland
9:15–9:45	Data-Driven Discovery at Boehringer Ingelheim: mAbs, ADCs, T-cell Engagers, and Beyond Julia Frei, Principal Scientist & Data Management Lead Biotherapeutics Discovery, Boehringer Ingelheim, Vienna, Austria
9:45–10:15	GSK's Biopharma Data Platform for End-to-End Data Science, Analytics, and Lab Automation Workflows Thil Batuwangala, Director Data Sciences - Large Molecule Discovery, GSK, Stevenage, UK
10:15–10:45	Mass Spec Data Digital Transformation at Lilly Biologic Discovery Joomi Ahn, Senior Director — Mass Spec Analytical BioTDR, Eli Lilly, San Diego, CA, USA
10:45–11:15	Break
11:15–11:45	Democratize Scientific Innovations: From Data Foundation to GxP Ready AI Assistants Sven-Eric Schelhorn, Associate Director Oncology Data Science, Merck, Darmstadt, Germany Ismael Velasco, Director of Global Data Insights & AI TRD, Novartis, Basel, Switzerland
11:45–12:30	Panel Discussion — Talking to Your Data: Accelerating Biopharma Innovation with GenAI and Beyond Moderated by Jana Hersch, Head of Science, Genedata Lore Florin, Senior Director Discovery Platforms, AstraZeneca Joel Bard, Research Fellow, BioMedicine Design, Pfizer Drazen Nadoveza, Complex Modalities Domain Architect, Novartis Sameh Eid, Associate Scientific Director — Digital, Data & IT Healthcare, Merck
12:30–2:00	Lunch
Breakout Sessions
	Biotherapeutics Discovery	Assay Analysis & Management	Mass-Spec Data Analysis	From Molecule to Medicine	Bioprocess Development
2:00–2:30	Smart Workflows for Smarter Therapeutics: From Antibody Hits to Leads at Genmab with Genedata Biologics Shushi Mita, Senior Scientist & Team Lead Antibody Discovery, Genmab, Utrecht, Netherlands	Automating High-Throughput MS Data Analysis with Genedata Rachel Moore, Associate Principal Scientist, AstraZeneca, Cambridge, UK		What Oncology Data Reveals: Exploring Biomarker Landscapes with Genedata Profiler Ryoko Takubo, Manager of Clinical Biomarker Bioanalysis Group, Pharmaceutical Science Department, Chugai, Tokyo, Japan	Recipe-Driven Experiment Management at AstraZeneca: Building on Genedata Bioprocess Robert Heckathorn, Senior Director Informatics and Software Engineering, AstraZeneca, Gaithersburg, MD, USA
2:30–3:00	Digitalizing the R&D of T-cell Receptors and Their Mimics for Enhanced, Machine Learning-Assisted Productivity Jakub Jaworski, Principal Research Scientist II — Protein Science Pipeline, Immunocore, Abingdon, UK	Accelerating Analysis of High-Throughput Covalent and Affinity Selection MS Screens Matt Bilyard, Senior Scientist, Roche, Basel, Switzerland Andreas Topp, Principal Scientist, Roche, Basel, Switzerland		End-to-End Biomarker Innovation: Linking Discovery, Analytics, and Diagnostic Translation for Alzheimer's Disease Jeremiah Hinson, Chief Scientific Office, Neurodegenerative Disease, Danaher Diagnostics, Baltimore, MD, USA Timo Wittenberger, Head of Science - Profiler, Genedata, Basel, Switzerland	Accelerating Microbiome CMC with a Global Data Framework Powered by Genedata Bioprocess Andre Ferreira, Senior Applications & Data Engineer, Ferring, Lisbon, Portugal
3:00–3:30	Break
3:30–4:00	Automating Global Antigen Design: How Sanofi Pasteur Accelerates Vaccine R&D with Genedata Biologics Bénédicte Billard, Business Product Owner, Sanofi, Lyon, France	Data, Data in the Well, Who’s the FAIRest of Them All? A Tale Where Happily-Ever-After Means End-to-End Automation with Screener & Biologics Tom Raes, Scientist Automation & Data Management, Sanofi, Ghent, Belgium	mRNA Critical Quality Attribute Analysis with Genedata Expressionist: Poly(A)-Tail and 5′-Capping Hannes Grieshammer, Mass Spectrometry Scientist, Bayer, Berlin, Germany	Digitalizing CMC Processes at Novartis – The Use Case of Solid Form Selection Anikó Udvarhelyi, Associate Director Data Science, Novartis, Basel, Switzerland	Closing the Loop: Chromatography Workflow Automation at Novartis Felix Stemmer, Senior Scientist, Novartis, Basel, Switzerland
4:00–4:30	AI/ML in Action: The Quest to Solve the Off-Target Problem for TCRms Benedetta Leoni, Bioinformatician, BioCopy, Emmendingen, Germany Stefan Kraemer, Scientist, BioCopy, Emmendingen, Germany	Smart Screening at Scale: Enabling Review by Exception Automation Michael Gallagher, Principal Scientist, Automation & Screening Operations, Johnson & Johnson, Spring House, PA, USA	Overcoming Challenges in Oligonucleotide Metabolite Identification with Tailored High-Resolution MS Workflow Katharina Root, Strategic Innovation Leader, Novartis, Basel, Switzerland	AI for Lipid Nanoparticles Andra St. Quintin, Senior Engineer, Cytiva, Vancouver, BC, Canada Malte Dyckmanns, Lead AI Software Engineer, Genedata, Munich, Germany	Genedata Bioprocess — Product Development Roadmap John Devane, Bioprocess Consultant, Genedata, Basel, Switzerland
4:30–5:00	Digital Transformation in Biotherapeutics Drug Discovery Alexander Horspool, Associate Director of Data and Lab Automation, Boehringer Ingelheim, Ridgefield, CT, USA	Panel Discussion — Challenges & Opportunities in Assay Automation Moderated by Gabriela Nass Kovács, Scientific Account Manager, Genedata Markus Kroemer, Director Data Science, Novartis, Basel, Switzerland Michael Gallagher, Data Operations Senior Scientist, Johnson & Johnson, Spring House, PA, USA Tom Raes, Senior Scientist, Automation and Data Workflow Lead, Sanofi, Ghent, Belgium Matthias Fassler, Product Manager, Genedata, Basel, Switzerland	Investigating Biotransformation of ADCs: An Integrated In Vitro Approach for Comprehensive Stability Assessment Marc Boehning, Senior Scientist in ADC & NBE Analytics, Merck, Darmstadt, Germany	AI‑First Genedata Profiler: Roadmap to Faster Scientific Decisions Marc Flesch, Managing Director, Genedata, Munich, Germany	Latest Release Highlights: Automation, Data Integrity, and Advanced Analytics Across USP, DSP, and Formulation Development Verena Thormann, Product Manager, Genedata, Basel, Switzerland
5:00	End of Day